ChemicalBook >> CAS DataBase List >>NEUROPEPTIDE W-30 (HUMAN)

NEUROPEPTIDE W-30 (HUMAN)

CAS No.
383415-80-3
Chemical Name:
NEUROPEPTIDE W-30 (HUMAN)
Synonyms
hL8;NPW;HL8C;PPL8;hPPL8;NPW23;NPW30;PPNPW;HPPL8 (33-62);NPW30 (HUMAN)
CBNumber:
CB0688044
Molecular Formula:
C165H249N49O37S
Molecular Weight:
3543.11
MDL Number:
MFCD06412271
MOL File:
383415-80-3.mol

NEUROPEPTIDE W-30 (HUMAN) Properties

Density 1.47±0.1 g/cm3(Predicted)
storage temp. −20°C

SAFETY

Risk and Safety Statements

WGK Germany  3

NEUROPEPTIDE W-30 (HUMAN) price

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
Usbiological 302088 Neuropeptide W-30, Human 383415-80-3 100ug $501 2021-12-16 Buy
Biorbyt Ltd orb372600 Neuropeptide W-30 > 95% 383415-80-3 1mg $688.5 2021-12-16 Buy
Biorbyt Ltd orb372601 Neuropeptide W-30 > 95% 383415-80-3 1mg $688.5 2021-12-16 Buy
Biorbyt Ltd orb372601 Neuropeptide W-30 > 95% 383415-80-3 5mg $1467.1 2021-12-16 Buy
Biorbyt Ltd orb372600 Neuropeptide W-30 > 95% 383415-80-3 5mg $1467.1 2021-12-16 Buy
Product number Packaging Price Buy
302088 100ug $501 Buy
orb372600 1mg $688.5 Buy
orb372601 1mg $688.5 Buy
orb372601 5mg $1467.1 Buy
orb372600 5mg $1467.1 Buy

NEUROPEPTIDE W-30 (HUMAN) Chemical Properties,Uses,Production

Structure

NPW cDNA encodes two forms of the peptide ligand with lengths of 23 and 30 aa residues as mature peptides, NPW23 and NPW30. These neuropeptides are derived from a common precursor protein, proNPW, by the proteolytic processing of two pairs of arginine residues at positions 24 and 25, and 31 and 32. Synthetic NPW23 activates and binds to two NPB/W receptors, NPBWR1 (GPR7) and NPBWR2 (GPR8), at similar effective doses. NPW precursor proteins are found in terrestrial vertebrate species, including mammals, birds, reptiles, and amphibians.  Human NPW23: Mr 2584.03; pI 10.28, Human NPW 30: Mr 3543.1; pI 11.0. Soluble in water. For best results, rehydrate just before use. After rehydration, keep solution at + 4°C for up to 5 days or freeze at -20°C for up to 3 months.

Gene, mRNA, and precursor

The gene encoding NPW maps to human chromosome 16p13.3. The gene encompasses 10.08 kb and is divided into two exons. Human NPW mRNA is 751 bp long. Among the porcine, rat, and human, the aa identities of NPW23 and NPW30 are 91.3% and 90.0%, respectively.  Based on RT-PCR analysis, NPW mRNA is highly expressed in the substantia nigra and spinal cord, and moderately expressed in the hippocampus, amygdala, hypothalamus corpus callosum, cerebellum, and dorsal root ganglia in the human central nervous system (CNS). In the peripheral tissues of rodents, Npw mRNA is expressed in the trachea, adrenocortical cells, gastric antral G cells, thyroid and parathyroid glands, pancreatic islets, ovary, and testis.

Receptors

Human NPBWR1 and NPBW2 genes are located on chromosome 10q11.2–121.1 and 20q13.3, respectively. Both receptors have 328 (36.1 kDa) and 333 (36.8 kDa) aa residues, respectively, and share 64% sequence homology with each other.8 NPBWR1 orthologs are highly conserved among other mammalian species. In contrast, the gene encoding NPBWR2 has not found in rodent genomes, suggesting that these two receptors were produced by relatively phylogenetically recent gene duplication. NPBWR1 and NPBWR2 couple to the Gi-class of G-proteins but not the Gq-class, suggesting that NPW has inhibitory properties on neurons via the activation of GIRK (Kir3) channels. NPW stimulated the PKA, PKC, p38 MAPK, and ERK1/2 activities in a dose- and time-dependent manner via NPBWR1 in the ATDC5 cells.

Biological functions

In mammals, NPW regulates many physiological processes such as food intake, energy homeostasis, obesity, neuroendocrine activity, and social behavior via its action on the CNS. In addition to the CNS, NPW and its receptors are expressed in the peripheral tissues of rodents or humans, such as the pancreas, stomach, adrenal cortex, anterior pituitary, and adipocytes. NPW may be involved in the control of adrenal corticosterone secretion, pancreatic insulin secretion, and lipolysis. Phenotype of gene-modified animals NPW knockout mice behave abnormally in response to life-threatening events (i.e., pain stimuli or a potential predator) when the environment is novel and/or distracting. NPBWR1 knockout male mice show late-onset obesity and hyperphagia, suggesting that the endogenous NPB/NPW-NPBWR1 pathway negatively regulates feeding behavior and positively regulates energy expenditure. However, these phenotypic characteristics are not observed in females.

Clinical implications

Direct linking between human diseases and the NPWNPBWR system has not been clarified yet. However, NPBWR1 modulates feeding, metabolism, and obesity in male mice. In humans, abdominal obesity is more prevalent in males, and is an independent risk factor for coronary heart disease. As activating or disrupting the NPW-NPBWR1 system does not have pronounced effects on growth and mortality in mice, NPBR1 and its ligand may be helpful for the discovery of therapeutic drugs and for designing therapies that overcome obesity and other lifestyle-related disorders .

Synthesis and release

In the rat stomach, NPW is secreted in response to the acute ingestion of a standard laboratory diet. Plasma NPW concentrations in fasting rats are low, and increase in response to feeding. Npw mRNA expression and the number of NPW-positive cells in the mouse antrum increase in diets including protein or glucose.

Description

The 23- or 30-aa neuropeptide identified as a ligand for two orphan G-protein-coupled receptors (GPR7 and GPR8), neuropeptide W (NPW) is involved in the regulation of feeding behavior and energy homeostasis via the neuronal circuits of the hypothalamus. O’Dowd et al. reported the existence of human genes encoding two structurally related orphan G protein-coupled receptors, NPBWR1 (GPR7) or NPBWR2 (GPR8).1 However, the endogenous ligand for these orphan receptors remained unknown until 2002. Shimomura et al. identified the mature peptide sequences of neuropeptide B (NPB) and neuropeptide W (NPW) from the porcine hypothalamus by reverse pharmacology.

NEUROPEPTIDE W-30 (HUMAN) Preparation Products And Raw materials

Raw materials

Preparation Products

NEUROPEPTIDE W-30 (HUMAN) Suppliers

Global( 47)Suppliers
Supplier Tel Email Country ProdList Advantage
Shenzhen Nexconn Pharmatechs Ltd
+86-755-89396905 +86-15013857715 admin@nexconn.com China 10311 58
Cellmano Biotech Limited
0551-65326643 18156095617 info@cellmano.com China 999 58
Career Henan Chemica Co
+86-0371-86658258 +8613203830695 laboratory@coreychem.com China 30239 58
Hangzhou Go Top Peptide Biotech
0571-88211921 sales1@gotopbio.com CHINA 2609 58
Chengdu Youngshe Chemical Co., Ltd.
+8618108235634 Cecilia@youngshechem.com China 2345 58
Nanjing TGpeptide
+86-13347807150 +86-13347807150 support@tgpeptide.com China 3279 58
Zhejiang Hangyu API Co., Ltd
+8617531972939 anna@api-made.com China 2943 58
Changsha MOL Changes Biotechnology Co., Ltd.
+8619375158599 info@molchanges.com China 5223 58
GL Biochem (Shanghai) Ltd 21-61263452 13641803416 ymbetter@glbiochem.com China 9981 64
Shanghai Hanhong Scientific Co.,Ltd. 021-54306202 13764082696 info@hanhongsci.com China 42958 64
PREPROPROTEIN L8 (33-62) (RAT) NEUROPEPTIDE W-30 (HUMAN) NPW30 (HUMAN) TRP-TYR-LYS-HIS-VAL-ALA-SER-PRO-ARG-TYR-HIS-THR-VAL-GLY-ARG-ALA-ALA-GLY-LEU-LEU-MET-GLY-LEU-ARG-ARG-SER-PRO-TYR-LEU-TRP TRP-TYR-LYS-HIS-VAL-ALA-SER-PRO-ARG-TYR-HIS-THR-VAL-GLY-ARG-ALA-ALA-GLY-LEU-LEU-MET-GLY-LEU-ARG-SER-PRO-TYR-LEU-TRP HL8C HPPL8 (33-62) H-TRP-TYR-LYS-HIS-VAL-ALA-SER-PRO-ARG-TYR-HIS-THR-VAL-GLY-ARG-ALA-ALA-GLY-LEU-LEU-MET-GLY-LEU-ARG-ARG-SER-PRO-TYR-LEU-TRP-OH Neuropeptide W-30 (huMan) NPW-30 (huMan), hPPL8 (33-62), Preproprotein L8 (33-62) (rat), hL8C NPW-30 (huMan), hPPL8 (33-62), Preproprotein L8 (33-62) (rat), hL8C ANTI-NPW (C-TERM) antibody produced in rabbit hL8 hPPL8 Neuropeptide W Neuropeptide W-23 Neuropeptide W-30 NPW NPW23 NPW30 PPL8 PPNPW Preproprotein L8 Neuropeptide W-30 (human) trifluoroacetate salt L-Tryptophan, L-tryptophyl-L-tyrosyl-L-lysyl-L-histidyl-L-valyl-L-alanyl-L-seryl-L-prolyl-L-arginyl-L-tyrosyl-L-histidyl-L-threonyl-L-valylglycyl-L-arginyl-L-alanyl-L-alanylglycyl-L-leucyl-L-leucyl-L-methionylglycyl-L-leucyl-L-arginyl-L-arginyl-L-seryl-L-prolyl-L-tyrosyl-L-leucyl- WYKHVASPRYHTVGRAAGLLMGLRSPYLW 383415-80-3 C165H249N49O37S